Background and objective: Virtual bronchoscopic navigation (VBN) entails the provision of a virtual display of the bronchial routes that lead to small peripheral pulmonary lesions (PPL). It has been predicted that a combination of computed tomography (CT)-guided transbronchial biopsy (CT-TBB) with VBN might improve the diagnostic yield for small PPL. This study sought to investigate that prediction. Methods: A total of 100 patients with small PPL (<20 mm) were enrolled for CT-TBB and randomly allocated to either a VBN+ or VBN− group (50 subjects per group). Group results were then compared in terms of diagnostic yield, whole procedure time, times at which the first CT scan and biopsy were taken and the number of lung biopsy specimens retrieved. Results: The diagnostic yield for small PPL was significantly higher in the VBN+ group versus VBN− group (84% vs 58%, respectively (P = 0.013)), with no significant difference in (whole) examination time between groups (VBN+: 32:53 (32 min and 53 s) AE 12:01 vs VBN−: 33:06 AE 10:08 (P = NS)). However, the time periods between commencing the examination and either the first CT scan or first biopsy were significantly shorter for the VBN+ group, while the net biopsy time tended to be longer for this group with a significantly higher number of specimens collected (VBN+: 3.54 AE 1.07 specimens vs VBN−: 2.98 AE 1.06 specimens (P = 0.01)). Conclusion: Combining VBN with CT-TBB significantly improved the diagnostic yield for small PPL.
INTRODUCTION
The development of computed tomography (CT)-related health screening now makes it possible to detect small peripheral pulmonary lesions (PPL) including lesions that are invisible by X-ray fluoroscopy. [1] [2] [3] As many as 57% of non-small cell lung cancer screened using low-dose CT are at stage IA. As a result, the early detection of these lesions has reduced mortality for lung cancer patients. 3 The diagnostic yield of small PPL with diameters of <20 mm remains problematic, with estimates of <30% when using conventional bronchoscopy under X-ray fluoroscopy. [4] [5] [6] To improve the diagnostic yield of PPL, advanced methods for diagnosing small PPL including endobronchial ultrasound with a guide sheath (EBUS-GS), electromagnetic navigation bronchoscopy (ENB) and CT-guided transbronchial biopsy (CT-TBB) have been developed. 2 Transthoracic percutaneous needle aspiration (TTNA) is an alternative and reliable diagnostic method. 7 Despite satisfactory diagnostic yields using TTNA and surgical resection, their associated 
SUMMARY AT A GLANCE
Computed tomography (CT)-guided transbronchial biopsy (CT-TBB) is one of the several procedures used to diagnose small peripheral pulmonary lesions (PPL), although its diagnostic yield is unsatisfying. We now report that a combined approach in which virtual bronchoscopic navigation (VBN) is used to assist CT-TBB improves the diagnostic yield for small PPL.
complications (e.g. air embolus, pneumothorax, haemoptysis, etc.) can be fatal. 7 In contrast, TBB is a relatively safe procedure and rarely provokes severe complications. 2 We previously reported that CT-TBB has an advantage with few occurrences of adverse effects. 11 However, the diagnostic yield of PPL by CT-TBB is relatively low. No reliable data have been available for virtual bronchoscopic navigation (VBN) supplemented CT-TBB. Therefore, we sought to apply VBN as an aid to CT-TBB with the expectation of improving the diagnostic yield for PPL.
METHODS

Study design
Patients were prospectively assigned to either VBN+ or VBN− groups. The VBN+ was referred to the bronchoscopic procedure of CT-TBB with aid of VBN; alternatively, VBN− was referred to the bronchoscopic procedure of CT-TBB without the aid of VBN. The senior doctors in our department recruited the patients for this study. Patients with small PPL (<20 mm in diameter) were recruited consecutively in Shinshu University Hospital from November 2011 to November 2014 (until 100 patients were collected). Every week, one patient recruited for the study underwent CTguided bronchoscopy. Patients were assigned to either the VBN+ or VBN− study group dependent on when they underwent CT-guided bronchoscopy. CT-guided bronchoscopy with aid of VBN was performed every other week and patients scheduled for CT-guided bronchoscopy in those weeks were assigned to the VBN+ study group. Patients undergoing CT-guided bronchoscopy during the weeks in between were assigned to the VBN− study group, which makes the study not truly randomized. However, no arbitrary manipulation interfered with this assignment. The primary endpoint was to improve the diagnostic yield of PPL. Clinical patient data (medical histories, clinical presentation, laboratory examinations, electrocardiograms (ECG), tests of pulmonary function and high-resolution CT (HRCT) scans) were carefully reviewed. This interventional trial was registered at the University Hospital Medical Information Network-Clinical Trial Registry (UMIN-CTR, UMIN000032484). Written informed consent was obtained for each patient prior to bronchoscopy, following the approval of our protocol by the Shinshu University Ethical Committee (permission number: 1958).
Small PPL
All small PPL (<20 mm in diameter) were detected by chest X-ray, CT scan or by a follow-up CT scans for other underlying disease. The definition of PPL are generally considered as lesions in the peripheral onethird of the lung, although a precise definition and radiographic anatomical landmarks separating central and peripheral lesion does not exist, 2, 6 and are not detectable beyond the visual segmental bronchi by flexible bronchoscopy. 6, 8, 9 The selection criteria for PPL included PPL that were invisible or unlikely to be detected by X-ray fluoroscopy, PPL that went undiagnosed despite examination by conventional bronchoscopy and difficult-to-access PPL in terms of conventional bronchoscopy. Patients were assigned in turn to either the VBN+ or VBN− groups for the CT-TBB examination (50 per group).
Definition of the CT-BS
The CT-bronchus sign (CT-BS) was used to describe the positional relationship of a PPL relative to a nearby bronchus. 10 For example, the term CT-BS 0 indicates no bronchus in proximity to the PPL, whereas CT-BS 1 indicates a bronchus adjacent to the PPL and CT-BS 2 indicates a bronchus within the PPL. CT-BS classifications were evaluated prior to CT-TBB. Given that PPL with a CT-BS designation of 0 were unlikely to receive a definitive diagnosis (as according to our previous study), 11 only PPL with classifications of CT-BS 1 or 2 were included in the present investigation.
Patient preparation before the CT-guided bronchoscopy
The patients were prepared for the CT-TBB as per previous description. 11 Briefly, topical anaesthesia with 2% lidocaine and conscious sedation with intramuscular pethidine hydrochloride were administered before the procedure, which was then monitored by pulse oximetry and ECG.
CT-TBB assisted by VBN
VBN images were constructed from HRCT scans by a navigation system (LungPoint Satellite Planning System, Broncus Technologies Inc., Mountain View, CA, USA) according to a previously described methodology. 12 Prior to examination, the bronchoscopist confirmed the virtual route to the target lesion by VBN. The examination was then performed in a room equipped with CT apparatus. Bronchoscopists with substantial expertise performed the CT-TBB assisted with VBN.
Bronchoscopy was performed as a routine procedure with a BF-type P260F (4.0 mm outer diameter, 2.0 mm channel diameter, Olympus, Tokyo, Japan) flexible bronchofibrevideoscope. Instead of X-ray fluoroscopy, a multi-detector CT (Aquilion 16; Toshiba, Tokyo, Japan) was used to guide the procedure. The application of VBN was as per previous description 12 and Appendix S1 (Supplementary Information). The position of the target lesion with respect to the tip of the biopsy forceps (FB-211D, Olympus) was confirmed by the first real-time multislice CT fluoroscopy (tube voltage: 120 kV; tube current: 10 mA; rotation time: 0.5 s; slice thickness: 2 mm). We repeated a subtle positional change of the forceps each time after a set of CT scanning within a narrow range containing both the lesion and the forceps, until we were sure that the tip of the forceps could capture the target. The biopsy was then performed as previously described. 11 The final procedure was to perform a bronchial wash using 10 mL of normal saline, with the bronchial lavage collected for cytological and bacterial analyses.
We tried to perform as many biopsies as possible until the patients felt fatigue and within the empirical length of examination time. The examination time was measured from the start of bronchoscopy to the termination of the procedure. In addition, the time intervals between beginning bronchoscopy and taking either the first CT scan or first biopsy were recorded. 13 The biopsy lung tissues were fixed with formalin for histological diagnoses. Lung tissue retrieved from the tips of the forceps was also evaluated by cytology. In this study, rapid on-site cytological examinations, cellblock and liquid-based cytology were not performed.
CT dose index
The CT dose index (CTDI) is a metric that quantifies the radiation output from multiple contiguous CT scans. In the present study, we used the CTDI to estimate radiation exposure during the procedure of CTguided bronchoscopy.
Diagnostic criteria
The diagnostic criteria of PPL were as described previously 11 and Appendix S1 (Supplementary Information). The definition of diagnostic yield in this paper was the percentage of the number of patients who obtained the definitive diagnosis by CT-TBB out of the total number of the patients in the given group.
Statistical analysis
We used Z-test with pooled variance of PASS 15.0.5 (NCSS, LLC Kaysville, UT, USA) for a sample size estimation. Based on our previous study of CT-TBB yield of 52.2% 11 and VBN-assisted EBUS yield of 80.4% 14 as reference yields of the study, we calculated the sample size with the statistical power of 0.80% and 5% on both sides to be a total of 100 subjects considering that there would be no drop out because all the recruited patients had agreed to perform the bronchoscopic examination in their informed consents.
Statistical analyses were with SPSS 14.0 (SPSS Inc., Chicago, IL, USA) for Windows (Microsoft Inc., Redmond, WA, USA). Performed statistical analyses are described in Appendix S1 (Supplementary Information).
RESULTS
Trial profile and basic characteristics of the patient cohort
The trial profile of this study was illustrated in Figure 1 . As shown in Table 1 , there were 23 men and 27 women in each of the groups (VBN+ and VBN−). No significant difference was found in the PPL diameter between the two groups.
Diagnostic yield of small PPL Diagnostic yields were 84.0% in the VBN+ group and 58.0% in the VBN− group, with a significant difference in diagnostic yield between the two groups (P = 0.013; Fig. 2 ). We performed brushing in two patients and TBNA in one patient in VBN+ group, but all the diagnostic yield was based on the biopsies and bronchial wash after biopsy. As a result, 47 patients in the VBN+ and 40 patients in the VBN− groups had final definitive diagnoses (Fig. 3) .
Factors that affect diagnostic yield
As shown in Table 2 , the number of biopsy specimens was significantly greater for the VBN+ group (n = 3.54 AE 1.07) versus VBN− group (n = 2.98 AE 1.06, P = 0.01). There was no significant difference in terms of whole examination time between groups (P = NS). However, time elapsed before the first CT, and the first biopsy, was significantly shorter for the VBN+ versus VBN− group (P < 0.01). There was no statistically significant difference in CTDI between the two groups (P = NS).
Complications and adverse events
Complications were observed in six patients in the VBN+ group and four patients in the VBN− group. There was no serious adverse event in both groups. The details of the complications were reported in Appendix S2 (Supplementary Information).
DISCUSSION
CT images enable fine visualization of a tiny positional gap between a small PPL and the forceps just before biopsy. In addition, the real-time CT can inspect the proper bronchus for the bronchoscopic route, with an aid of VBN to further confirm the route reaching the Figure 1 Trial profile. Bronchoscopic examination was performed in a total of 1336 patients during the study period. In 430 patients, bronchoscopy was performed for the diagnoses of PPL. Of whom, 308 patients were examined with conventional bronchoscopy or EBUS-GS. In the rest of 122 patients, CT-TBB was performed. Of the 122 patients, 22 patients were excluded in the recruitment including 3 patients with PPL in size >20 mm, 9 patients with PPL of CT-BS 0 and 10 patients whose clinical data (e.g. examination time, CT dose index, etc.) were unqualified. As a result, 100 patients were recruited in the study and assigned in turn into VBN+ (n = 50) and VBN− (n = 50) groups. BAL, broncho-alveolar lavage; BF, bronchofiberscopy; BS, bronchus sign; CT, computed tomography; EBUS-GS, endobronchial ultrasound with a guide sheath; PPL, peripheral pulmonary lesion; TBLB, transbronchial lung biopsy; VBN, virtual bronchoscopic navigation.
PPL. This is the first prospective, single-centre trial to examine the value of using a VBN system to assist CT-TBB in the diagnosis of PPL.
Similar to CT-guided bronchoscopy, EBUS-GS is a reliable diagnostic procedure for small PPL with a diagnostic yield of 58-77% for all lesion sizes. [15] [16] [17] In particular, for those patients with PPL with positive CT-BS, diagnostic yields of 77-89% have been reported. 15, 16, 18 Previous studies have reported that VBN might be used to guide biopsy forceps to small PPL. 19, 20 Ishida et al. reported a greater diagnostic yield when using VBN-assisted EBUS-GS for small PPL of <30 mm (80.4% vs 67.0% with and without VBN, respectively (P = 0.032)). The diagnostic yield of PPL <20 mm in size was 75.9% versus 59.3%, with and without VBN respectively, when calculated from this study. 14 The present investigation demonstrated that VBN could be used to increase the diagnostic yield for PPL of <20 mm in diameter using CT-TBB. The diagnostic yield of small PPL was 84.0% in the group with VBN versus 58.0% for the group without VBN. The improved diagnostic yield of 84.0% for VBN-assisted CT-TBB (in the present investigation) exceeds that achieved (80.4%) when combining EBUS-GS with VBN. 14 The diagnostic yield of lesions <2 cm by percutaneous CT-guided biopsy is also high; the diagnostic accuracy is 92.8% with a sensitivity for malignancy at 92.3%, 21 but this technique carries the risk of complications such as pneumothorax, bleeding, 22 air embolism, 23, 24 and even an increased risk of pleural recurrence in stage I lung cancer. 25 Therefore, in our opinion, the PPL of negative CT-BS or undiagnosed PPL by CT-TBB should be considered an alternative choice of the diagnostic procedure to perform TTNA. Using TBNA during CT-guided bronchoscopy might be an alternative procedure in patients of negative CT-BS. Mondoni et al. reported that using TBNA under X-ray fluoroscopy brought about good yield of 0.70 in CT-BS (+) nodule in size >3 cm. 8 However, there are some differences from our study. First, our targets were the PPL in size smaller than 20 mm; second, it was not preferred to obtain samples by using TBNA during CTguided bronchoscopy because the CT fluoroscopy could not follow the tip of the needle in real time while the needle was advanced to the target lesion, and thus the risk of pneumothorax was increased, which was proved in our previous study.
11
CT-TBB is especially applicable to those patients of PPL that are unresectable because of physical or mental problems, for which there is a strong suspicion of lung carcinoma. In fact, up to 60% of the nodules were not malignant in some studies. 26 Indeed, in our study, 52 of the 100 patients necessitated confirmation of a definitive diagnosis prior to resection because of poor cardiopulmonary condition (15 patients), a history of other pulmonary cancer (7 patients), multiple lung cancer (7 patients), a possibility of benign disease (2 patients), a suspicion of metastatic lung cancer (3 patients), refused surgical procedure (6 patients), multiple co-morbidities (10 patients) and severe mental NS † Age and PPL diameter were expressed as mean AE SD. ‡ Conventional CT-TBB (without VBN) was performed on this patient before the present study. BS, bronchus sign; CT, computed tomography; EBUS-GS, endobronchial ultrasound with a guide sheath; F, female; M, male; n, number; NS, not significant; PPL, peripheral pulmonary lesion; TBB, transbronchial biopsy; VBN, virtual bronchoscopic navigation. disease (2 patients). In addition, 33 individuals in this 100-patient cohort were over 75 years of age.
The examination time was controlled to be as short as possible in order to reduce radiation exposure. There was no significant difference in the average examination time between groups (Table 2) . On the other hand, the time elapsed prior to the first biopsy was longer for the VBN− group ( Table 2 ), such that a greater proportion of the examination time could be used to collect biopsy material for the VBN+ group, with more biopsies collected. In a previous study of the diagnostic yield for PPL TBB suggested that larger specimen numbers might lead to an improved diagnostic yield. 27 In our previous study, although the diagnostic yield did not differ significantly between PPL involving one biopsy versus those involving multiple specimens, there was a tendency for an increased specimen number to lead to a better diagnostic yield. 11 We anticipated that VBN-assisted bronchoscopy might lead to a reduction in radiation exposure. However, there was no significant difference in radiation exposure for the VBN+ versus VBN− groups (Table 2) . Larger numbers of biopsy specimens might cause an increase in CT scans. To reduce radiation exposure in CT-guided bronchoscopy, other methods (e.g. rapid on-site cytological evaluation) might be of benefit in shortening the examination time.
The CT apparatus can be used for CT-TBB in few hospitals. In our hospital, we have one CT apparatus that is designated only for the invasive examinations. In the insurance system of Japan, CT-TBB costs 450 dollars per examination, EBUS-GS costs 410 dollars and Figure 3 Final diagnosis. In the VBN+ group, of those 42 patients who got definitive diagnosis, 41 were malignant tumours (38 patients of adenocarcinoma, 2 of squamous cell carcinoma and 1 of metastatic lung carcinoma) and 1 was inflammation. Of those eight patients who could not obtain the diagnosis, five had surgery and diagnosed with adenocarcinoma, one received radiation therapy and two were followed up periodically by CT scanning. In the VBN− group, of those 29 patients who got definitive diagnosis, 27 were malignant tumours (26 patients of adenocarcinoma and 1 of metastatic lung cancer) and two were inflammations. Of those 21 patients who could not obtain the diagnosis, 11 had surgery diagnosed with adenocarcinoma, one received radiation therapy as lung cancer, eight were followed up periodically by CT scanning and one went to another hospital and lost to follow-up. Numbers in the parenthesis indicate the number of patients. CT, computed tomography; TBB, transbronchial biopsy; VBN, virtual bronchoscopic navigation. no cost charge for using VBN. We believe the use of CT-TBB is likely to be cost-effective, but are now studying the advantages of CT-TBB over EBUS-GS in the diagnosis of small PPL, to help guide the appropriate future use of CT-TBB.
The limitation of the study is that the patients were assigned alternatively to either VBN+ or VBN− groups, which was not true randomization in clinical study. Additionally, patients with CT-BS 1 and 2 only were included. Based on our previous study, CT-TBB was not recommended to perform on patients with CT-BS 0 because of the low diagnostic yield at 2.9%. 11 Nevertheless, excluding the CT-BS 0 might be a limitation to have bias in the patient selection.
In conclusion, VBN significantly improved the diagnostic yield of small PPL in CT-guided bronchoscopy. A data availability Statement needs to be included for a CT study.
